Level Bio AB (NGM:LEVBIO) Total Assets: kr13.12 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LEVBIO Level Bio AB NGM:LEVBIO
23 GF Score
Price kr0.30
! 4 Warning Signs
View Full Analysis

What is Level Bio AB Total Assets?

Level Bio AB NGM:LEVBIO -21.58% 23 Total Assets is kr13.12 Mil as of Mar. 2026. GuruFocus rates NGM:LEVBIO with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

Level Bio AB's Total Assets for the quarter that ended in Mar. 2026 was kr13.12 Mil.

During the past 12 months, Level Bio AB's average Total Assets Growth Rate was -4.40% per year. During the past 3 years, the average Total Assets Growth Rate was -18.00% per year. During the past 5 years, the average Total Assets Growth Rate was -1.60% per year. During the past 10 years, the average Total Assets Growth Rate was 3.00% per year.

During the past 13 years, Level Bio AB's highest 3-Year average Total Assets Growth Rate was 39.20%. The lowest was -18.30%. And the median was -5.95%.

Total Assets is connected with ROA %. Level Bio AB's annualized ROA % for the quarter that ended in Mar. 2026 was -4.98%. Total Assets is also linked to Revenue through Asset Turnover. Level Bio AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.66.

Level Bio AB  (NGM:LEVBIO) Total Assets Explanation

Total Assets is connected with ROA %.

Level Bio AB's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-0.676/( (14.051+13.12)/ 2 )
=-0.676/13.5855
=-4.98 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Level Bio AB's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=8.995/( (14.051+13.12)/ 2 )
=8.995/13.5855
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Level Bio AB Total Assets Related Terms

Level Bio AB Total Assets Historical Data

* Premium members only.

The historical data trend for Level Bio AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB Total Assets Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.06 28.80 19.09 15.37 14.05

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.54 13.19 13.24 14.05 13.12
NGM:LEVBIO
23GF Score
Level Bio AB NGM:LEVBIO
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Level Bio AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=0.637+13.414
=14.05

Level Bio AB's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=0.468+12.652
=13.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of kr13.12 Mil mean?
Level Bio AB (NGM:LEVBIO) has a Total Assets of kr13.12 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Level Bio AB and its competitors.
Is Level Bio AB's Total Assets too high?
Level Bio AB's current Total Assets is kr13.12 Mil. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Total Assets compare to TMO and DHR?
Level Bio AB's Total Assets of kr13.12 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Diagnostics & Research company?
A good Total Assets depends on the Medical Diagnostics & Research industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Level Bio AB and its competitors. Level Bio AB's current Total Assets is kr13.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (NGM:LEVBIO) has a current Total Assets of kr13.12 Mil. The current Total Assets is kr13.12 Mil. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Level Bio AB (NGM:LEVBIO), the current Total Assets is kr13.12 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score

Get the complete analysis for NGM:LEVBIO

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.30
Price